XML 61 R51.htm IDEA: XBRL DOCUMENT
v3.24.3

Accounts Receivable - Additional Information (Detail) | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Sep. 30, 2024 USD ($) | Sep. 30, 2024 USD ($) Distributor | Dec. 31, 2023 USD ($) Distributor
Accounts Receivable [Line Items] |  |  |
Number of wholesale distributors | Distributor |  | 3 | 3
Percentage of gross sales from major wholesale distributors | 77.00% | 73.00% |
Allowance for credit losses and doubtful accounts | $ 0 | $ 0 | $ 0
Percentage of revenue from major customers collaborations and services | 100.00% | 100.00% |
Zealand Pharma US |  |  |
Accounts Receivable [Line Items] |  |  |
Allowance for credit losses and doubtful accounts |  |  | $ 200,000
United Therapeutics Corporation |  |  |
Accounts Receivable [Line Items] |  |  |
Percentage of collaborations and services net accounts receivables |  | 100.00% | 100.00%
Commercial product sales |  |  |
Accounts Receivable [Line Items] |  |  |
Percentage of accounts receivable from major wholesale distributors | 87.00% | 87.00% |
Allowance for credit losses and doubtful accounts | $ 0 | $ 0 | $ 157,000
Accounts receivable | $ 18,359,000 | $ 18,359,000 | $ 20,199,000

X
- Definition Number of wholesale distributors. + References No definition available. + Details
Name: | mnkd_NumberOfWholesaleDistributors
Namespace Prefix: | mnkd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of accounts receivable from major customers. + References No definition available. + Details
Name: | mnkd_PercentageOfAccountsReceivableFromMajorCustomers
Namespace Prefix: | mnkd_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of collaborations and services net accounts receivables. + References No definition available. + Details
Name: | mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables
Namespace Prefix: | mnkd_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of revenue from major customers collaborations and services. + References No definition available. + Details
Name: | mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices
Namespace Prefix: | mnkd_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of sales from major customers. + References No definition available. + Details
Name: | mnkd_PercentageOfSalesFromMajorCustomers
Namespace Prefix: | mnkd_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 310 -SubTopic 20 -Name Accounting Standards Codification -Section 40 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2 + Details
Name: | us-gaap_AccountsNotesAndLoansReceivableLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1 + Details
Name: | us-gaap_AccountsReceivableGrossCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of allowance for credit loss on accounts receivable, classified as current. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4 + Details
Name: | us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_ZealandPharmaUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |